# Actinium Pharmaceuticals, Inc.: Form DEF 14A, filed Nov 5, 2024

- Company: [Actinium Pharmaceuticals, Inc.](/companies/atnm.md) (CIK 1388320)
- Form: DEF 14A
- Filed: 2024-11-05
- Accepted by EDGAR: Nov 5, 2024, 22:00 ET
- Period: 2024-11-27
- Accession: 0001213900-24-094619
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1388320/000121390024094619/ea0219744-01.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1388320/000121390024094619/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1388320/000121390024094619/ea0219744-01.htm

Filed Nov 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-094619. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.
